Resmed Inc. buy KeyCorp
Start price
06.02.24
/
50%
€178.25
Target price
06.02.25
€211.50
Performance (%)
28.64%
End price
07.02.25
€229.30
Summary
This prediction ended on 07.02.25 with a price of €229.30. The prediction had a final performance of 28.64%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.87 was paid as dividends for this prediction. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -1.667% | -1.667% | -12.557% |
| iShares Core DAX® | 1.130% | 2.184% | 15.737% |
| iShares Nasdaq 100 | 1.128% | -0.611% | 7.324% |
| iShares Nikkei 225® | 2.610% | 4.958% | 20.446% |
| iShares S&P 500 | -0.006% | -0.952% | 2.166% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten